###begin article-title 0
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
Common polymorphisms within the NR4A3 locus, encoding the orphan nuclear receptor Nor-1, are associated with enhanced beta-cell function in non-diabetic subjects
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 384 390 384 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
Neuron-derived orphan receptor (Nor) 1, nuclear receptor (Nur) 77, and nuclear receptor-related protein (Nurr) 1 constitute the NR4A family of orphan nuclear receptors which were recently found to modulate hepatic glucose production, insulin signalling in adipocytes, and oxidative metabolism in skeletal muscle. In this study, we assessed whether common genetic variation within the NR4A3 locus, encoding Nor-1, contributes to the development of prediabetic phenotypes, such as glucose intolerance, insulin resistance, or beta-cell dysfunction.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 264 270 262 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 293 295 291 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
We genotyped 1495 non-diabetic subjects from Southern Germany for the five tagging single nucleotide polymorphisms (SNPs) rs7047636, rs1526267, rs2416879, rs12686676, and rs10819699 (minor allele frequencies >/= 0.05) covering 100% of genetic variation within the NR4A3 locus (with D' = 1.0, r2 >/= 0.9) and assessed their association with metabolic data derived from the fasting state, an oral glucose tolerance test (OGTT), and a hyperinsulinemic-euglycemic clamp (subgroup, N = 506). SNPs that revealed consistent associations with prediabetic phenotypes were subsequently genotyped in a second cohort (METSIM Study; Finland; N = 5265) for replication.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 257 266 255 264 <sub xmlns:xlink="http://www.w3.org/1999/xlink">C-peptide</sub>
###xml 273 278 271 276 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Gluc </sub>
###xml 295 300 293 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Ins30</sub>
###xml 307 314 305 312 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Gluc30 </sub>
All five SNPs were in Hardy-Weinberg equilibrium (p >/= 0.7, all). The minor alleles of three SNPs, i.e., rs1526267, rs12686676, and rs10819699, consistently tended to associate with higher insulin release as derived from plasma insulin at 30 min(OGTT), AUCC-peptide-to-AUCGluc ratio and the AUCIns30-to-AUCGluc30 ratio with rs12686676 reaching the level of significance (p </= 0.03, all; additive model). The association of the SNP rs12686676 with insulin secretion was replicated in the METSIM cohort (p </= 0.03, additive model). There was no consistent association with glucose tolerance or insulin resistance in both study cohorts.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 101 107 101 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
We conclude that common genetic variation within the NR4A3 locus determines insulin secretion. Thus, NR4A3 represents a novel candidate gene for beta-cell function which was not covered by the SNP arrays of recent genome-wide association studies for type 2 diabetes mellitus.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A1</italic>
###xml 144 149 144 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A2</italic>
###xml 202 207 202 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3</italic>
###xml 495 496 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 578 579 578 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 598 599 598 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 626 627 626 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 628 629 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 650 651 650 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 652 653 652 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 681 682 681 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 697 698 697 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1054 1056 1054 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1040 1045 <span type="species:ncbi:10090">mouse</span>
The NR4A family of orphan nuclear receptors comprises nuclear receptor (Nur) 77 (gene: NR4A1), nuclear receptor-related protein (Nurr) 1 (gene: NR4A2), and neuron-derived orphan receptor (Nor) 1 (gene: NR4A3). These ligand-independent constitutively active transcription factors are co-expressed in many metabolically relevant tissues, such as skeletal muscle, adipose tissue, liver, heart, and brain, and are thought to be predominantly regulated at the transcriptional level (for review, see [1]). In this context, a plethora of stimuli was identified, including fatty acids [2], growth factors [3], inflammatory cytokines [4,5], peptide hormones [6,7], membrane depolarisation [8], and stress [9], regulating NR4A family member expression in a tissue-specific manner. Recently, important metabolic functions of NR4A transcription factors were revealed. All three NR4A family members are induced in the liver upon fasting and glucagon stimulation, and their hepatic expression was found to be increased in both type 1 and type 2 diabetic mouse models [10].
###end p 11
###begin p 12
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 202 208 202 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A1 </italic>
###xml 221 227 221 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
Moreover, adenoviral over-expression of these receptors induced the expression of gluconeogenetic enzymes and enhanced hepatic glucose production in vitro as well as in vivo [10]. In 3T3-L1 adipocytes, NR4A1 (Nur-77) and NR4A3 (Nor-1) expression was reported to be induced upon insulin and thiazolidinedione treatment.
###end p 12
###begin p 13
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 529 535 529 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
Furthermore, the expression of both receptors was found to be decreased in skeletal muscle and adipose tissue of multiple rodent models of insulin resistance and diabetes [11]. As lentiviral Nor-1 over-expression additionally was shown to enhance adipocyte insulin signalling and glucose transporter-4 translocation [11] and siRNA knock-down showed that Nor-1 regulates gene expression for oxidative metabolism in skeletal muscle [12], we asked whether common genetic variation within the genetic locus harbouring the Nor-1 gene NR4A3 (OMIM ID 600542, Entrez Gene ID 8013) contributes to the development of prediabetic phenotypes, especially such as glucose intolerance and insulin resistance.
###end p 13
###begin p 14
###xml 284 290 282 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 316 318 314 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
To this end, we genotyped 1495 non-diabetic subjects from Southern Germany for the five tagging single nucleotide polymorphisms (SNPs) rs7047636, rs1526267, rs2416879, rs12686676, and rs10819699 (minor allele frequencies (MAFs) >/= 0.05) covering 100% of genetic variation within the NR4A3 locus (with D' = 1.0 and r2 >/= 0.9) and assessed their association with metabolic data derived from the fasting state, an oral glucose tolerance test (OGTT), and, in a subgroup of 506 subjects, from a hyperinsulinemic-euglycemic clamp. Found SNP-genotype associations were subjected to further analysis in the METSIM Study cohort from Finland (N = 5265) for replication purposes.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
###xml 6 18 <span type="species:ncbi:9606">participants</span>
Study participants
###end title 16
###begin title 17
TUF/TULIP cohort
###end title 17
###begin p 18
###xml 48 50 48 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T&#252;</bold>
###xml 57 58 57 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 78 80 78 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Tu</bold>
###xml 88 89 88 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L</bold>
###xml 98 99 98 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 111 112 111 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink">P</bold>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 203 204 203 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 28 40 <span type="species:ncbi:9606">participants</span>
###xml 158 170 <span type="species:ncbi:9606">participants</span>
###xml 415 427 <span type="species:ncbi:9606">participants</span>
Data from 1495 non-diabetic participants of the Tubingen Family Study and the Tuebingen Lifestyle Intervention Program [13] were analyzed for this study. The participants (characteristics given in Table 1) did not take any medication known to affect glucose tolerance or insulin secretion, and were requested not to smoke 24 h before and during the test period. Informed written consent was obtained from all study participants, and the local ethics committee has approved the protocol.
###end p 18
###begin p 19
Clinical characteristics of the TUF/TULIP and METSIM study population.
###end p 19
###begin p 20
Data are given as means +/- SD. BMI - body mass index; IFG - impaired fasting glucose (defined as 100-126 mg/dl according to AHA guidelines); IGT - impaired glucose tolerance; OGTT - oral glucose tolerance test.
###end p 20
###begin title 21
METSIM cohort
###end title 21
###begin p 22
###xml 4 7 4 7 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MET</bold>
###xml 14 15 14 15 <bold xmlns:xlink="http://www.w3.org/1999/xlink">S</bold>
###xml 23 24 23 24 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 26 27 26 27 <bold xmlns:xlink="http://www.w3.org/1999/xlink">M</bold>
###xml 154 155 154 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 521 523 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 26 29 <span type="species:ncbi:9606">Men</span>
###xml 87 90 <span type="species:ncbi:9606">men</span>
###xml 168 180 <span type="species:ncbi:9606">participants</span>
###xml 370 382 <span type="species:ncbi:9606">participants</span>
###xml 437 449 <span type="species:ncbi:9606">participants</span>
The METabolic Syndrome In Men (METSIM) Study addresses a random sample of 6147 Finnish men aged from 45 to 70 years in Eastern Finland (Kuopio, see Table 1). All study participants underwent an oral glucose tolerance test (OGTT, see below), and the study protocol was approved by the local ethics committee. For the study of prediabetic traits, only non-diabetic METSIM participants were analyzed (N = 5265, aged 58 +/- 6 years). METSIM participants with newly diagnosed diabetes (N = 882) according to the WHO criteria [14] allowed estimation for diabetes risk using logistic regression analysis.
###end p 22
###begin title 23
Anthropometrics
###end title 23
###begin p 24
###xml 84 85 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
Body mass index (BMI) was calculated as weight divided by the square of height (kg/m2). Body fat was determined by bioelectrical impedance (RJL, Detroit, MI, USA).
###end p 24
###begin title 25
Analytical procedures
###end title 25
###begin p 26
Blood glucose was measured with a bedside glucose analyzer (Yellow Springs Instruments, Yellow Springs, OH, USA). Plasma insulin and C-peptide concentrations were measured by commercial chemiluminescence assays for ADVIA Centaur (Siemens Medical Solutions, Fernwald, Germany) according to the manufacturer's instructions. In the METSIM Study, plasma glucose was measured by enzymatic hexokinase photometric assay (Konelab Systems Reagents, Thermo Fischer Scientific, Vantaa, Finland), and insulin was determined by immunoassay (ADVIA Centaur Insulin IRI, no 02230141, Siemens Medical Solutions Diagnostics, Tarrytown, NY).
###end p 26
###begin title 27
Oral glucose tolerance test
###end title 27
###begin p 28
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
The oral glucose tolerance test was performed according to the WHO recommendations after a 12-h fasting period [14]. In addition to plasma glucose, C-peptide levels and plasma insulin were measured at 0, 30, 60, 90 and 120 min in the TUF/TULIP cohort. In the METSIM Study, plasma glucose and insulin levels were measured at 0, 30 and 120 min.
###end p 28
###begin title 29
Calculations on insulin sensitivity and insulin secretion
###end title 29
###begin p 30
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 568 577 568 577 <sub xmlns:xlink="http://www.w3.org/1999/xlink">C-peptide</sub>
###xml 584 589 584 589 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Gluc </sub>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 742 747 742 747 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Ins30</sub>
###xml 754 761 754 761 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Gluc30 </sub>
###xml 776 782 776 782 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0 min </sub>
###xml 791 797 791 797 <sub xmlns:xlink="http://www.w3.org/1999/xlink">30 min</sub>
###xml 806 812 806 812 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0 min </sub>
###xml 821 827 821 827 <sub xmlns:xlink="http://www.w3.org/1999/xlink">30 min</sub>
###xml 970 972 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 225 237 <span type="species:ncbi:9606">participants</span>
Insulin sensitivity was estimated from insulin and glucose values obtained during the OGTT according to the (HOMA) homeostasis model assessment [15] or the method proposed by Matsuda and DeFronzo [16]. In 506 TUF/TULIP Study participants, insulin sensitivity was additionally measured by a euglycemic hyperinsulinemic clamp, as described elsewhere [17]. In TUF/TULIP, insulin secretion was estimated from insulin plasma levels measured at 30 min of the OGTT and the area under the curve (AUC) of C-peptide levels divided by the corresponding AUC of plasma glucose (AUCC-peptide-to-AUCGluc ratio) levels [18]. In both study cohorts, insulin secretion was estimated from insulin plasma levels measured at 30 min during the OGTT and from the AUCIns30-to-AUCGluc30 ratio [(insulin0 min + insulin30 min)/glucose0 min + glucose30 min)] that recently has been shown to be the best surrogate parameter for first phase insulin secretion in an intravenous glucose tolerance test [19].
###end p 30
###begin title 31
Genotyping and selection of tagging SNPs
###end title 31
###begin p 32
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 390 396 390 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 504 506 502 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
Genomic DNA was isolated from EDTA blood samples by blood cell lysis, protein precipitation and a washing protocol as previously described [17]. Genotyping was accomplished by use of the TaqMan Assay (Eurogentec, Liege, Belgium) and an ABI Prism 7500 sequence detection system (Applied Biosystems, Foster City, CA, USA) for selected tagging SNPs. Selection criteria for tagging SNPs of the NR4A3 locus on chromosome 9q22 were a minor allele frequency (MAF) >/= 0.05 and a linkage disequilibrium measure r2 </= 0.8 in the CEU population of the HapMap project (Utah residents with ancestry from Northern and Western Europe).
###end p 32
###begin title 33
###xml 28 33 <span type="species:ncbi:9606">human</span>
Gene expression analyses in human islet and adipose tissue
###end title 33
###begin p 34
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 818 822 803 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 576 581 <span type="species:ncbi:9606">human</span>
Pancreata were obtained from brain-dead multiorgan donors and islet isolations were performed as previously described according to the Ricordi method with local (Geneva) adaptations [20,21]. Briefly, the pancreas was distended by intraductal infusion of a cold collagenase solution. After digestion at 37degreesC in a modified Ricordi chamber, separated exocrine and endocrine tissues were washed and purified in a continuous Biocoll gradient. After several washings, islets were incubated in CMRL 1066 medium containing 5.6 mM glucose. RNA was extracted from cultivated (2d) human islets and adipose tissue specimens with PeqGOLD Tri Fasttrade mark (PEQLAB Biotechnologie, Erlangen, Germany) according to the protocol supplied by the manufacturer, and quantitative real-time PCR was performed with Roche's LightCycler(R) 480 (Roche, Basel, Switzerland).
###end p 34
###begin title 35
Statistical analyses
###end title 35
###begin p 36
###xml 54 55 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 520 521 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 643 645 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
The Hardy-Weinberg equilibrium was tested with the chi2-test. Three-group comparisons without adjustments were performed using ANOVA. In addition, multivariate linear regression models with adjustments to relevant covariates were undertaken for genotype-phenotype association analyses. Non-normally distributed parameters were log-transformed. All data are presented as means +/- SD. The software package JMP 7.0 (SAS Institute, Cary, NC, USA) and SPSS 14.0 (SPSS, Chicago, IL, USA) was used for statistical analysis. A p-value < 0.05 was considered to be statistically significant. Linkage disequilibrium was analyzed with the JLIN software [22].
###end p 36
###begin title 37
Results
###end title 37
###begin title 38
Study population
###end title 38
###begin p 39
###xml 415 416 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 485 491 479 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 636 637 630 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 279 291 <span type="species:ncbi:9606">participants</span>
###xml 302 305 <span type="species:ncbi:9606">men</span>
###xml 441 453 <span type="species:ncbi:9606">participants</span>
The TUF/TULIP Study cohort of 1495 (506 male/989 female) non-diabetic subjects had a mean age of 39 +/- 13 years. 10% had an impaired fasting glucose (IFG), 9.5% showed an impaired glucose tolerance (IGT) and 7.6% presented with both IFG and IGT in the OGTT. METSIM non-diabetic participants (N = 5265 men) had an average age of 58 +/- 6 years, and 16.6 (9.5; 6.5)% were diagnosed with IFG (IGT; IFG+IGT; see Table 1). A total of 882 METSIM participants (59 +/- 6 years) genotyped for NR4A3 were diagnosed with diabetes. Further details on basal anthropometric and metabolic traits of the investigated populations are provided in Table 1.
###end p 39
###begin title 40
Genetic analyses
###end title 40
###begin p 41
###xml 23 29 23 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 157 163 157 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 270 271 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 535 536 531 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 622 624 618 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 646 647 642 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
HapMap analysis of the NR4A3 locus revealed five tagging SNPs (rs7047636, rs1526267, rs2416879, rs12686676 and rs10819699) to cover 100% of variation in the NR4A3 gene locus (55 kb) including 5 kb of its 5'-flanking region and 5 kb of its 3'-flanking region (see Figure 1). Genotype call rates were > 98.4% for all investigated SNPs, and minor allele frequencies of the tagging SNPs ranged from 0.10 (rs2416879) to 0.46 (rs12686676; see Table 2) in the TUF/TULIP cohort. All SNPs were in Hardy-Weinberg equilibrium (p >/= 0.7, all; chi2-test), and linkage disequilibrium of the five selected tagging SNPs was rather low (r2 < 0.6, all; see Table 2).
###end p 41
###begin p 42
###xml 0 185 0 183 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Fifty-five-kb genomic region of human chromosome 9q22 harbouring the NR4A3 gene and HapMap LD data of the 17 common (minor allele frequency &#8805; 0.05) informative SNPs within this region</bold>
###xml 191 197 189 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 669 671 667 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 706 708 704 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 32 37 <span type="species:ncbi:9606">human</span>
Fifty-five-kb genomic region of human chromosome 9q22 harbouring the NR4A3 gene and HapMap LD data of the 17 common (minor allele frequency >/= 0.05) informative SNPs within this region. The NR4A3 gene consists of eight exons and seven introns and spans 45 kb from nucleotide 101,623,958 to nucleotide 101,668,994. The locations of the five tagging SNPs rs7047636, rs1526267, rs2416879, rs12686676, and rs10819699 are indicated by black arrows. The Haploview LD colour scheme 'R-squared' was chosen to visualize regions of high linkage disequilibrium (black diamonds: complete LD; dark grey diamonds: strong LD; light grey diamonds: weak LD). Within the diamonds, the r2 values are given (black diamonds: r2 = 1.0). LD - linkage disequilibrium; SNP - single nucleotide polymorphism.
###end p 42
###begin p 43
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
Linkage disequilibrium statistics (D', r2) among the five tagging SNPs rs7047636, rs1526267, rs2416879, rs12686676, and rs10819699 covering the 55-kb genomic locus harbouring the NR4A3 gene in the screening population (TUF/TULIP cohort).
###end p 43
###begin p 44
D' values above empty cells; r(2) values below empty cells. SNP - single nucleotide polymorphism, MAF - minor allele frequency
###end p 44
###begin title 45
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
Association of NR4A3 SNPs with anthropometric and metabolic traits in TUF/TULIP
###end title 45
###begin p 46
###xml 607 608 607 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 630 631 630 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 953 954 951 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 1078 1087 1076 1085 <sub xmlns:xlink="http://www.w3.org/1999/xlink">C-peptide</sub>
###xml 1094 1099 1092 1097 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Gluc </sub>
###xml 1109 1114 1107 1112 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Ins30</sub>
###xml 1121 1128 1119 1126 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Gluc30 </sub>
###xml 1141 1142 1139 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 1206 1208 1204 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1237 1239 1235 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1322 1331 1320 1329 <sub xmlns:xlink="http://www.w3.org/1999/xlink">C-peptide</sub>
###xml 1338 1343 1336 1341 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Gluc </sub>
###xml 1517 1522 1515 1520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3</italic>
###xml 1623 1624 1621 1622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1648 1649 1646 1647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1765 1771 1763 1769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 1923 1928 1921 1926 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Ins30</sub>
###xml 1935 1942 1933 1940 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Gluc30 </sub>
###xml 2001 2002 1999 2000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
We found a significant association of the minor allele of rs7047636 with increased plasma glucose at 120 min of the OGTT (p = 0.03, additive model, adjusted for age, gender and BMI). The minor allele of rs1526267 was associated with a higher BMI (p = 0.02, additive model, adjusted for age and gender) and with decreased insulin sensitivity measured by clamp (p = 0.03, additive model, adjusted for age, gender and BMI). We did not detect any significant association of the four other tagging SNPs with BMI, body fat, blood glucose levels (fasting state and 120 min OGTT) and insulin sensitivity (see Table 3 and [Additional file 1]). The most consistent finding in the TUF/TULIP population was a trend towards an association of the minor alleles of rs1526267, rs12686676 and rs10819699 with increased insulin secretion, with rs12686676 reaching the level of significance (p </= 0.03 after adjustment for age, gender, BMI and insulin sensitivity; Table 3). This finding was independent of the insulin secretion estimation model used for the analysis (insulin at 30 min OGTT, AUCC-peptide-to-AUCGluc ratio, AUCIns30-to-AUCGluc30 ratio; Table 3). All these findings could be reproduced if the Matsuda model [16] instead of the HOMA model [15] was used as an estimate of insulin sensitivity. In the dominant model of e.g. AUCC-peptide-to-AUCGluc ratio, the increase in insulin secretion amounted to 6.2% for rs1526267, 6.0% for rs12686676 and 3.7% for rs10819699. The intronic SNP rs1526267 is in a very low LD with the NR4A3-3'-flanking SNPs rs12686676 and rs10819699 in both the CEU population of the HapMap project (Figure 1) and our cohort (Table 2), and the fact that three rather independent SNPs associate with insulin secretion further underscores the role of NR4A3 in beta-cell function. The SNP rs2416879 also showed a significant association with two insulin secretion estimation models (insulin at 30 min OGTT, AUCIns30-to-AUCGluc30 ratio; p < 0.001 for adjusted models, [see Additional file 1]). However, no clear allele dose effect could be detected. Therefore, we doubted about the reliability of this finding and did not replicate this SNP in the METSIM Study.
###end p 46
###begin p 47
###xml 16 22 16 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
Associations of NR4A3 SNPs rs1526267, rs12686676 and rs10819699 with anthropometric and metabolic data (TUF/TULIP cohort, N = 1495)
###end p 47
###begin p 48
###xml 86 88 84 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 85 88 83 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">p<sub>1 </sub></bold>
###xml 120 122 118 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 119 122 117 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink">p<sub>2 </sub></bold>
###xml 334 343 332 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink">C-peptide</sub>
###xml 350 355 348 353 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Gluc </sub>
###xml 365 370 363 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Ins30</sub>
###xml 377 384 375 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Gluc30 </sub>
###xml 463 465 461 463 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 462 465 460 463 <bold xmlns:xlink="http://www.w3.org/1999/xlink">p<sub>3 </sub></bold>
Data are given as means +/- SD. For statistical analysis, data were log-transformed. p1 - non-adjusted additive model; p2 - adjusted additive model: age was adjusted for gender; BMI and body fat were adjusted for gender and age; glucose (Gluc) levels as well as insulin sensitivity (HOMA model, clamp) and insulin (Ins) secretion (AUCC-peptide-to-AUCGluc ratio, AUCIns30-to-AUCGluc30 ratio, plasma insulin at 30 min OGTT) were adjusted for gender, age, and BMI; p3 - Ins secretion parameters with adjustment for age, BMI, gender and insulin sensitivity. *clamped subgroup (N = 506). AUC - area under the curve; BMI - body mass index; OGTT - oral glucose tolerance test; SNP - single nucleotide polymorphism.
###end p 48
###begin title 49
Replication in the METSIM Study
###end title 49
###begin p 50
###xml 316 321 316 321 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Ins30</sub>
###xml 328 335 328 335 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Gluc30 </sub>
###xml 616 617 616 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 678 684 678 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 1104 1105 1104 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1197 1203 1197 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 1405 1406 1405 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 520 532 <span type="species:ncbi:9606">participants</span>
###xml 907 919 <span type="species:ncbi:9606">participants</span>
###xml 1371 1383 <span type="species:ncbi:9606">participants</span>
Next, we tried to replicate the most reliable associations between SNPs (rs1526267, rs12686676, rs10819699) and insulin secretion in the METSIM cohort. Adjustment for age, BMI and insulin sensitivity (HOMA) revealed a significant association with both insulin secretion estimation models (insulin at 30 min OGTT, AUCIns30-to-AUCGluc30 ratio) in rs12686676, which yet showed the most convincing association in the TUF/TULIP Study. In contrast to TUF/TULIP, rs1526267 had no effect on BMI or insulin sensitivity in METSIM participants, and both rs1526267 and rs10819699 did not associate with insulin secretion (Table 4). Since the METSIM Study design also allows the analysis of NR4A3 genetic variants for the endpoint diabetes in a population-based cohort, we tested whether rs1526267, rs12686676 or rs10819699 associated with the prevalence of diabetes. However, comparing diabetic with non-diabetic study participants by logistic regression analysis did not reveal a significantly altered diabetes prevalence in minor allele carriers of the three investigated SNPs (p > 0.11; all, [see Additional file 2]). There were also no significant differences in genotype distribution of the investigated NR4A3 SNPs according to the glucose tolerance status (normal glucose tolerance, impaired fasting glucose, impaired glucose tolerance, diabetes) of both TUEF/TULIP and METSIM participants [see Additional file 3].
###end p 50
###begin p 51
Associations of NR4A3 SNPs rs1526267, rs12686676 and rs10819699 with metabolic data and insulin secretion indices (METSIM cohort, N = 5265)
###end p 51
###begin p 52
###xml 86 88 84 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 85 88 83 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">p<sub>1 </sub></bold>
###xml 120 122 118 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 119 122 117 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink">p<sub>2 </sub></bold>
###xml 174 176 172 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 173 176 171 174 <bold xmlns:xlink="http://www.w3.org/1999/xlink">p<sub>3 </sub></bold>
###xml 181 186 179 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Ins30</sub>
###xml 193 200 191 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Gluc30 </sub>
Data are given as means +/- SD. For statistical analysis, data were log-transformed. p1 - non-adjusted additive model; p2 - additive model with adjustements to BMI and age; p3 - AUCIns30-to-AUCGluc30 ratio and plasma insulin at 30 min OGTT with adjustements for age, BMI and insulin sensitivity; AUC - area under the curve; OGTT - oral glucose tolerance test; SNP - single nucleotide polymorphism, Gluc - Glucose, Ins - Insulin.
###end p 52
###begin title 53
###xml 20 25 <span type="species:ncbi:9606">human</span>
NR4A3 expression in human islets
###end title 53
###begin p 54
###xml 412 418 412 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RPS13 </italic>
###xml 450 455 450 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRS2 </italic>
###xml 493 494 493 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 235 240 <span type="species:ncbi:9606">human</span>
NR4A3 gene expression was determined in four independent, freshly isolated, human islet preparations. Signal intensities of NR4A3 were comparable for all four islet preparations. Interestingly, NR4A3 signals were ~1.5 fold stronger in human islets as in two samples of adipose tissue included as a positive control, and remarkably high in comparison to two other positive controls, namely the house-keeping gene RPS13 (40S ribosomal protein S13) and IRS2 (insulin-receptor-substrate 2; Figure 2).
###end p 54
###begin p 55
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 0 37 0 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>NR4A3 </italic>gene expression in human islets</bold>
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 106 111 <span type="species:ncbi:9606">human</span>
NR4A3 gene expression in human islets. RNA was isolated from four independent (islet1-4) freshly isolated human islet preparations, and NR4A3 gene expression was determined with quantitative real-time PCR in comparison with the house-keeping gene RPS13 (40S ribosomal protein S13) and insulin-receptor-substrate 2 (IRS2). RNA preparations of two adipose tissue samples were included as a positive control for NR4A3 expression analysis.
###end p 55
###begin title 56
Discussion
###end title 56
###begin p 57
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 124 130 124 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 361 367 361 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 995 1001 995 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 1177 1179 1177 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1468 1470 1468 1470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1471 1473 1471 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1498 1503 1498 1503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3</italic>
This study investigated the role of NR4A3 for metabolic traits in a prediabetic population. Our primary hypothesis was that NR4A3 variants may associate with glucose intolerance or insulin resistance, based on published data on Nor-1 functions in liver and skeletal muscle [10-12,23]. However, we did not detect any convincing associations between the selected NR4A3 tagging SNPs and glucose intolerance/insulin resistance in the two investigated study cohorts. Contrary to our expectation, the principal finding was that three out of the five investigated tagging SNPs, namely rs1526267, rs12686676, and rs10819699, showed a consistent trend towards an association with insulin secretion in the TUF/TULIP cohort, with rs12686676 reaching a significant level after adjustment for confounding variables. This finding could be replicated in a second independent cohort of Finnish male subjects (METSIM Study). Summarizing our data obtained from both cohorts, we assume a rather dominant effect of NR4A3 on insulin secretion. However, further research is needed to verify this hypothesis in other cohorts, as all other detected diabetes risk genes show an additive allele effect [24]. It is of note that the tested SNPs were not covered by the SNP arrays used in recent genome-wide association studies (GWA), according to currently available statistic data . Interestingly, most diabetes genes detected by the GWA studies are also involved in insulin secretory function [25-28], as it is the case for NR4A3.
###end p 57
###begin p 58
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 213 219 213 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 325 331 325 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 418 424 418 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 367 372 <span type="species:ncbi:9606">human</span>
As the effect of NR4A3 on insulin secretion was not dependent on the levels of non-esterified fatty acids as a read-out of adipose tissue metabolism determined in our study cohort (data not shown), we assume that NR4A3 genetic variability is an independent determinant for insulin secretion. Our finding of a remarkably high NR4A3 gene expression in freshly isolated human islets also supports a physiological role of NR4A3 in beta cells. Further evidence for this hypothesis arises from a study on target genes of a fusion protein encoded by a t(9;22) chromosomal translocation. The resulting EWS/NOR-1 fusion induces serum- and glucocorticoid-regulated kinase 1 (SGK1) [29], which mediates inhibition of insulin release in insulin-secreting cells [30].
###end p 58
###begin p 59
###xml 66 72 66 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 163 169 163 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A1 </italic>
###xml 173 179 173 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 647 649 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
As mentioned above, there was no replicable significant effect of NR4A3 genetic variability on insulin sensitivity in the two study populations, despite that both NR4A1 and NR4A3 expression is reduced in skeletal muscle of various diabetic animal models [11] and increased in L6 skeletal muscle cells and muscle biopsies upon insulin stimulation [31] or dietary restriction [32]. We also were not able to show a replicable association with BMI in our two study cohorts. This finding may reflect the fact that the NR4A family of nuclear orphan receptors was shown to be dispensable for adipogenesis, at least in the 3T3L1 adipocyte cellular model [33].
###end p 59
###begin p 60
###xml 350 356 346 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 466 475 462 471 <sub xmlns:xlink="http://www.w3.org/1999/xlink">C-peptide</sub>
###xml 482 487 478 483 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Gluc </sub>
###xml 497 502 493 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Ins30</sub>
###xml 509 516 505 512 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Gluc30 </sub>
###xml 769 771 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 794 800 790 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 1098 1099 1094 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
The following limitations of our study should be addressed: we did not a priori correct our data for multiple comparisons. Bonferroni correction for 5 independently analyzed SNPs (corrected alpha-level: 0.0102) would render all reported findings nominal. However, association with insulin secretion was consistently seen in three tagging SNPs in the NR4A3 gene and independent of the model used for estimation of insulin secretion (plasma insulin at 30 min OGTT, AUCC-peptide-to-AUCGluc ratio, AUCIns30-to-AUCGluc30 ratio) in the TUF/TULIP Study cohort, and the most significant association of rs12686676 could be replicated in a second larger population (METSIM Study). As recent GWA studies mainly detected genes involved in insulin secretion as diabetes risk genes [24], one may assume that NR4A3 genetic variants have an impact on diabetes prevalence. Surprisingly, this was not the case in the METSIM cohort. As the METSIM study (diabetes prevalence: 13.8%) provides a power of 80% to detect a genotype relative risk of 1.15 assuming a SNP minor allele frequency of ~0.35 [see Additional file 3], we conclude that NR4A3 genetic variability may confer a rather modest effect on diabetes risk, and that analysis of this locus necessitates even larger replication samples.
###end p 60
###begin title 61
Conclusion
###end title 61
###begin p 62
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 321 327 321 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
We are confident that the described association between NR4A3 genetic variants and insulin secretion is not a by-chance finding, and that further research on the role of orphan nuclear receptors in beta cell function and diabetes pathogenesis is warranted. In addition, it would be interesting to investigate the role of NR4A3 genetic variants in large studies employing a case-control design.
###end p 62
###begin title 63
Competing interests
###end title 63
###begin p 64
The authors declare that they have no competing interests.
###end p 64
###begin title 65
Authors' contributions
###end title 65
###begin p 66
###xml 279 291 <span type="species:ncbi:9606">participants</span>
###xml 462 467 <span type="species:ncbi:9606">human</span>
###xml 577 584 <span type="species:ncbi:9606">patient</span>
###xml 704 711 <span type="species:ncbi:9606">patient</span>
PW and HS were responsible for the complete statistical analysis and prepared all tables, figures and the manuscript. AS did the complete statistical analysis for the METSIM cohort and prepared tables and the manuscript. SAS and KK made contributions to phenotyping of TUF/TULIP participants. FM is responsible of the genotyping facility at the University of Tubingen and additionally performed the real-time PCR studies. SU, FR and BG provided freshly isolated human islet preparations. ML and JK are the principal investigators of the METSIM Study and responsible for METSIM patient and data management. NS, AF and HUH acted as principal investigators for the TUF/TULIP study, and were responsible for patient and data management. All authors read and approved the final manuscript.
###end p 66
###begin title 67
Pre-publication history
###end title 67
###begin p 68
The pre-publication history for this paper can be accessed here:
###end p 68
###begin p 69

###end p 69
###begin title 70
Supplementary Material
###end title 70
###begin title 71
Additional file 1
###end title 71
###begin p 72
###xml 16 22 16 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR4A3 </italic>
###xml 0 118 0 118 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Associations of <italic>NR4A3 </italic>SNPs rs7047636 and rs2416879 with anthropometric and metabolic data (T&#220;F/TULIP cohort, N = 1495)</bold>
###xml 206 208 204 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 240 242 238 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 454 463 452 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink">C-peptide</sub>
###xml 470 475 468 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Gluc </sub>
###xml 485 490 483 488 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Ins30</sub>
###xml 497 504 495 502 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Gluc30 </sub>
###xml 583 585 581 583 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
Associations of NR4A3 SNPs rs7047636 and rs2416879 with anthropometric and metabolic data (TUF/TULIP cohort, N = 1495). Data are given as means +/- SD. For statistical analysis, data were log-transformed. p1 - non-adjusted additive model; p2 - adjusted additive model: age was adjusted for gender; BMI and body fat were adjusted for gender and age; glucose (Gluc) levels as well as insulin sensitivity (HOMA model, clamp) and insulin (Ins) secretion (AUCC-peptide-to-AUCGluc ratio, AUCIns30-to-AUCGluc30 ratio, plasma insulin at 30 min OGTT) were adjusted for gender, age, and BMI; p3 - Ins secretion parameters with adjustment for age, BMI, gender and insulin sensitivity. *clamped subgroup (N = 506). AUC - area under the curve; BMI - body mass index; OGTT - oral glucose tolerance test; SNP - single nucleotide polymorphism.
###end p 72
###begin p 73
Click here for file
###end p 73
###begin title 74
Additional file 2
###end title 74
###begin p 75
###xml 0 188 0 188 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Logistic regression analysis for differences of NR4A3 SNP's minor allele prevalences in individuals with normal glucose tolerance (NGT) and overt diabetes mellitus (DM) in the METSIM Study</bold>
Logistic regression analysis for differences of NR4A3 SNP's minor allele prevalences in individuals with normal glucose tolerance (NGT) and overt diabetes mellitus (DM) in the METSIM Study. The [95%] confidence interval of the data provided is indicated for all different statistical models (additive, dominant, recessive) for all investigated SNPs.
###end p 75
###begin p 76
Click here for file
###end p 76
###begin title 77
Additional file 3
###end title 77
###begin p 78
###xml 0 149 0 149 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Distribution of NR4A3 SNP minor allele frequencies according to glucose tolerance status in the T&#220;F/TULIP (N = 1495) and the METSIM (N = 6147) cohort</bold>
###xml 433 435 433 435 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 477 478 475 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 487 489 485 487 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 527 528 523 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 232 244 <span type="species:ncbi:9606">participants</span>
###xml 412 424 <span type="species:ncbi:9606">participants</span>
Distribution of NR4A3 SNP minor allele frequencies according to glucose tolerance status in the TUF/TULIP (N = 1495) and the METSIM (N = 6147) cohort. Minor allele frequencies for each investigated NR4A3 SNP are presented for study participants (TUEF-TULIP/METSIM trial) with normal glucose tolerance (NGT), impaired fasting glucose and/or impaired glucose tolerance (IFG/IGT) and with manifest diabetes (METSIM participants only). p1 - NGT vs. IFG/IGT in TUEF-TULIP/METSIM(chi2-test); p2 - NGTvs.IFG/IGTvs.DIABETESinMETSIM(chi2-test). SNPs screened in TUEF/TULIP only and not replicated in METSIM are marked with an asterisk.
###end p 78
###begin p 79
Click here for file
###end p 79
###begin title 80
Acknowledgements
###end title 80
###begin p 81
###xml 19 31 <span type="species:ncbi:9606">participants</span>
###xml 468 473 <span type="species:ncbi:9606">Human</span>
We thank all study participants for their cooperation. We thank the International HapMap Consortium for the public allocation of genotype data. We gratefully acknowledge the excellent technical assistance of Alke Guirguis, Melanie Weisser, Anna Bury, Heike Luz and Roman-Georg Werner. The study was supported in part by grants from the German Research Foundation (KFO 114/2 and GA386/9-1) and the European Community's frame program FP6 EUGENE 2 (LSHM-CT-2004-512013). Human islets were obtained from Geneva through the European Consortium for Islet Transplantation (ECIT), supported by JDRF, grant number 31-2008-416.
###end p 81
###begin article-title 82
The NR4A subgroup: immediate early response genes with pleiotropic physiological roles
###end article-title 82
###begin article-title 83
Palmitate and oleate induce the immediate-early response genes c-fos and nur-77 in the pancreatic beta-cell line INS-1
###end article-title 83
###begin article-title 84
A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily
###end article-title 84
###begin article-title 85
###xml 75 80 <span type="species:ncbi:9606">human</span>
Induction of mitogen-inducible nuclear orphan receptor by interleukin 1 in human synovial and gingival fibroblasts
###end article-title 85
###begin article-title 86
Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli
###end article-title 86
###begin article-title 87
Regulation of the nuclear orphan receptor Nur77 in bone by parathyroid hormone
###end article-title 87
###begin article-title 88
Parathyroid hormone induces expression of the nuclear orphan receptor Nurr1 in bone cells
###end article-title 88
###begin article-title 89
Differential regulation of the transcriptional activity of the orphan nuclear receptor NGFI-B by membrane depolarization and nerve growth factor
###end article-title 89
###begin article-title 90
###xml 47 50 <span type="species:ncbi:10116">rat</span>
Induction of multiple immediate early genes in rat hypothalamic paraventricular nucleus after stress
###end article-title 90
###begin article-title 91
NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism
###end article-title 91
###begin article-title 92
NR4A orphan nuclear receptors modulate insulin action and the glucose transport system: potential role in insulin resistance
###end article-title 92
###begin article-title 93
The orphan nuclear receptor, NOR-1, a target of beta-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle
###end article-title 93
###begin article-title 94
Lifestyle intervention in individuals with normal versus impaired glucose tolerance
###end article-title 94
###begin article-title 95
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
###end article-title 95
###begin article-title 96
###xml 130 133 <span type="species:ncbi:9606">man</span>
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
###end article-title 96
###begin article-title 97
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp
###end article-title 97
###begin article-title 98
Role of AMP-activated protein kinase gamma 3 genetic variability in glucose and lipid metabolism in non-diabetic whites
###end article-title 98
###begin article-title 99
Within-subject variability of measures of beta cell function derived from a 2 h OGTT: implications for research studies
###end article-title 99
###begin article-title 100
###xml 114 117 <span type="species:ncbi:9606">men</span>
Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men
###end article-title 100
###begin article-title 101
###xml 34 39 <span type="species:ncbi:9606">human</span>
Automated method for isolation of human pancreatic islets
###end article-title 101
###begin article-title 102
###xml 59 64 <span type="species:ncbi:9606">human</span>
Assessment of a novel two-component enzyme preparation for human islet isolation and transplantation
###end article-title 102
###begin article-title 103
JLIN: a java based linkage disequilibrium plotter
###end article-title 103
###begin article-title 104
Orphan nuclear receptor NOR-1 enhances 3',5'-cyclic adenosine 5'-monophosphate-dependent uncoupling protein-1 gene transcription
###end article-title 104
###begin article-title 105
The emerging genetic architecture of type 2 diabetes
###end article-title 105
###begin article-title 106
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes
###end article-title 106
###begin article-title 107
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
###end article-title 107
###begin article-title 108
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
###end article-title 108
###begin article-title 109
A genome-wide association study identifies novel risk loci for type 2 diabetes
###end article-title 109
###begin article-title 110
Serum- and glucocorticoid-regulated kinase 1 (SGK1) induction by the EWS/NOR1(NR4A3) fusion protein
###end article-title 110
###begin article-title 111
Serum- and glucocorticoid-inducible kinase 1 (SGK1) mediates glucocorticoid-induced inhibition of insulin secretion
###end article-title 111
###begin article-title 112
###xml 73 78 <span type="species:ncbi:9606">human</span>
The effect of insulin on expression of genes and biochemical pathways in human skeletal muscle
###end article-title 112
###begin article-title 113
###xml 125 129 <span type="species:ncbi:10116">rats</span>
Whole-genome microarray analysis identifies up-regulation of Nr4a nuclear receptors in muscle and liver from diet-restricted rats
###end article-title 113
###begin article-title 114
The NR4A family of orphan nuclear receptors are not required for adipogenesis
###end article-title 114

